Infectious Diseases Market Research Reports & Industry Analysis
Infectious Diseases Industry Research & Market Reports
-
2025 Certain Infectious and Parasitic Diseases Global Market Size & Growth Report with Updated Country Recession Risk Forecasts
... 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling certain infectious and parasitic diseases ... Read More
-
In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) & Region- Global Forecast to 2030
... increasing global burden of chronic diseases such as diabetes, cardiovascular conditions, cancer, and infectious diseases (e.g., HIV, tuberculosis). Demand for faster results, decentralized testing, and home-based diagnostics are pushing growth in point-of-care (POC) testing devices, ... Read More
-
Molecular Diagnostics Market Report by Product (Reagents and Kits, Instruments, Software and Services), Technology (Polymerase Chain Reactions (PCR), Hybridization, DNA Sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), and Others), Application (Infectious Diseases Diagnostics, Oncology, Genetic Testing, Blood Screening, and Others), End Users (Hospitals, Laboratories, and Others), and Region 2025-2033
... The increasing prevalence of infectious diseases and genetic disorders, technological advancements in polymerase chain reaction (PCR), growing aging population, surging awareness of early disease detection, and supportive government initiatives are factors shaping the market's trajectory. ... Read More
-
Global Infectious Disease Diagnostics Market 2025-2029
... disease diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Humanized Mouse and Rat Model Market by Type (Genetic Models, Cell-based Models, Rat Models), Application (Oncology, Immunology, Neuroscience, Toxicology, Infectious Diseases), End User (Pharma, Biotech), and Region - Global Forecast to 2030
... a high CAGR due to rising R&D investments of pharmaceutical and biopharmaceutical firms. As the pipeline of R&D expands, the requirement for outsourcing analytical testing is set to rise, in addition to the research initiatives ... Read More
-
2025 Global: Hospital Acquired Infection Control Market - Innovative Markets Forecast (2031) report
... accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only ... Read More
-
Infectious Disease Specialists in the US - Industry Market Research Report
... size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares. Read More
-
Legionella Control (UK) - Industry Report
... the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Legionella Control (UK) report will tell you the companies that have ... Read More
-
Zika Virus Testing
... at a CAGR of 5.8% over the analysis period 2024-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$192.4 Million by the end of ... Read More
-
Pneumonia Therapeutics
... CAGR of 6.7% over the analysis period 2024-2030. Drugs, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$6.8 Billion by the end of the analysis period. ... Read More
-
Antibiotics
... 3.1% over the analysis period 2024-2030. Penicillin, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$15.7 Billion by the end of the analysis period. Growth in ... Read More
-
Anti-Infectives
... 6.2% over the analysis period 2024-2030. Anti-Viral Drugs, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$117.1 Billion by the end of the analysis period. Growth ... Read More
-
Sepsis Therapeutics
... CAGR of 6.3% over the analysis period 2024-2030. Cephalosporin, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$3.1 Billion by the end of the analysis period. ... Read More
-
Infection Surveillance Solutions
... at a CAGR of 16.3% over the analysis period 2024-2030. Software, one of the segments analyzed in the report, is expected to record a 15.6% CAGR and reach US$1.3 Billion by the end of the ... Read More
-
Infectious Disease Therapeutics
... at a CAGR of 7.1% over the analysis period 2024-2030. HIV, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$113.7 Billion by the end of the ... Read More
-
Infectious Disease Diagnostics
... at a CAGR of 5.5% over the analysis period 2024-2030. Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion by the end ... Read More
-
Pneumonia Testing
... CAGR of 6.2% over the analysis period 2024-2030. Immunodiagnostics, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$339.9 Million by the end of the analysis period. ... Read More
-
Contract Research Organization Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Early Phase Development Services, Clinical Research Services, Laboratory Services, and Post-Approval Services), Product Type (Cell and Gene Therapy, Biosimilars, Antibody Drug Conjugates, and Others), Type (In-house and Outsource), Application (Oncology, Neurology, Cardiology, Infectious Diseases, Metabolic Disorder, Nephrology, Respiratory, Dermatology, Ophthalmology, Hematology, and Others), End User (Pharmaceutical and Biotech Companies, Medical Device Companies, Academic and Research Institutes, and Others) and Geography
... driving the market growth include increased outsourcing of R&D and rising demand for clinical trials further are likely to boost the market during the forecast period. However, high competition among CROs among the market deterrents. ... Read More
-
West Nile Virus Market, By Product Type (Antivirals, Vaccines, Antibiotics, Analgesics, and Others), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
... of the world, including North America, Europe, and Asia. The virus is primarily transmitted to humans through the bite of infected mosquitoes. WNV can cause a range of symptoms, from mild flu-like illness to severe ... Read More
-
Physician Office Diagnostic Market, By Product Type (Point-of-Care Testing (POCT) Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics, and Urinalysis Systems), By End User (Physician Offices and Clinics, Urgent Care Centers, and Ambulatory Care Centers), By Application (Infectious Diseases, Cardiovascular Disorders, Metabolic Disorders, Cancer Diagnosis, Pregnancy and Fertility Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... are anticipated to drive growth of the global physician office diagnostic market over the forecast period. Moreover, increasing focus on personalized medicine is also expected to boost growth of the global physician office diagnostic market ... Read More
-
Oral Solid Dosage Manufacturing Market by Type of Finished Dosage Form
... by 2035, at a CAGR of 4.49% during the forecast period, till 2035. The market sizing and opportunity analysis has been segmented across the following parameters: Type of Finished Dosage Form Tablets Capsules Powders Multi-particulates ... Read More
-
RNA Therapeutics and RNA Vaccines Market by Type of Modality
... 68% during the forecast period, till 2035. The market sizing and opportunity analysis has been segmented across the following parameters: Type of Modality RNA Therapeutics RNA Vaccines Type of Molecule Replicating RNA Self Amplifying RNA ... Read More
-
mRNA Therapeutics Market Size, Share, and Outlook, 2025 Report- By Product (Vaccines, Drugs), By Application (Infectious Diseases, Rare Genetic Diseases, Respiratory Diseases, Others), By End-user (Hospitals & Clinics, Research & Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on mRNA Therapeutics segments across 22 countries from 2021 to 2032. ... Read More
-
mRNA Therapeutics Contract Development & Manufacturing Market Size, Share, and Outlook, 2025 Report- By Application (Viral Vaccines, Protein Replacement Therapies, Cancer Immunotherapies), By Indication (Infectious Diseases, Metabolic & Genetic Diseases, Cardiovascular & Cerebrovascular Diseases), By End-user (Biotech Companies, Pharmaceutical companies, Government & Academic Research Institutes), 2021-2032
... & Manufacturing market is a thriving business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast ... Read More
-
Respiratory Disease Vaccine Market Size, Share, and Outlook, 2025 Report- By Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine), By Age group (Pediatric, Adult), By Infection, COVID-19, Influenza, Respiratory Syncytial Virus, Pneumonia, Others), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Others), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Respiratory Disease Vaccine segments across 22 countries ... Read More
Research Assistance
